Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2004

Jan 2, 2004

29777_dirs_2004-01-02_9d1e1b38-fbdc-4efa-ab97-e36b06ccc551.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2003-12-31

Reporting Person: MCCULLOUGH GARY E (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-12-31 Common shares without par value A 40000 $46.62 Acquired 40000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2003-12-31 Option (right to buy) $46.62 A 100000 Acquired 2013-12-30 Common shares (100000) Direct

Footnotes

F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.

F2: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 33,334, 33,333, and 33,333 beginning on December 31, 2004, the first anniversary date of the grant.